UnitedHealth Group shares fell Wednesday, September 9, 2026, after news broke that the company sold an interest in its Florida senior-clinic business to private equity firm TPG — the same day UnitedHealth executives were addressing investors at a major healthcare conference. Shares dropped about 3% in early trading, to roughly $388.58 — a decline measured against the previous session’s closing price. The slide deepened as the day wore on, and at an intraday low near $378.08, shares were down as much as 5.2% from that same previous close.
Key facts
- Stock drop: UnitedHealth (UNH) shares fell about 3% in early trading Wednesday, September 9, 2026, to roughly $388.58
- Intraday low: shares touched roughly $378.08, down as much as 5.2% from the previous close
- Deal: private equity firm TPG bought a stake in the Florida clinics run by WellMed, part of Optum Health — deal size and price undisclosed
- Dividend: Some market-data summaries cite a $2.32-per-share quarterly dividend with a September 14, 2026 record date
- Guidance reaffirmed: full-year 2026 adjusted EPS of $19.50 to $20.00 and roughly $24 billion in operating cash flow
- Not related to the roughly 20% drop on January 27, 2026, which followed weak Q4 2025 earnings and a separate DOJ (Department of Justice) investigation
Timeline
- January 27, 2026 — UnitedHealth shares fell roughly 20% after weak fourth-quarter 2025 earnings, the company’s first-ever revenue-decline warning, and Medicaid margin problems, alongside a separate Justice Department antitrust investigation into its Claritev subsidiary
- March 2026 — TPG bought UnitedHealth’s Optum UK subsidiary, a sale that generated $400 million for the United Health Foundation
- September 9, 2026 — UnitedHealth shares fall after TPG buys a stake in its Florida WellMed clinics, the same day executives address the Wells Fargo Healthcare Conference
- September 14, 2026 — Record date cited by some market-data summaries for UnitedHealth’s $2.32 quarterly dividend
What UnitedHealth sold
UnitedHealth sold an interest in part of Optum Health, its care-delivery arm, specifically the Florida clinics run by WellMed, which provide primary care mostly to older, Medicare-age patients. The buyer, TPG Inc., is a private equity firm; neither company disclosed the size of the stake or what TPG paid for it. UnitedHealth said it is opening roughly 15 new WellMed clinics a year in Florida, and the TPG deal is meant to speed that expansion up.
CFO Wayne DeVeydt told Bloomberg News the move was about bringing in a partner with local expertise, not about raising cash: “We didn’t need the dollars, we have the dollars to invest, but we needed the focus and somebody that could actually work with us locally.” Reporting quoted Optum Health CEO Krista Nelson as saying the company brought in a partner to make more investment in the market and pursue strategic growth. TPG also acquired UnitedHealth’s Optum UK subsidiary in March 2026, a sale the company said generated $400 million for the United Health Foundation.
What executives told investors the same day
The stock move came as UnitedHealth executives spoke at the Wells Fargo Healthcare Conference, where management said the company’s broader turnaround is “gaining traction.” They pointed to stronger Medicare Advantage performance, a steadier outlook for Medicaid, and cost cuts from automation and AI, and they reaffirmed full-year 2026 guidance of $19.50 to $20.00 in adjusted earnings per share and roughly $24 billion in operating cash flow. DeVeydt also said Optum Health’s operating margin is on track to reach about 2% this year, up from prior expectations, and guided toward roughly 4% next year.
Not everything in the update was upbeat: executives also acknowledged continuing weakness in part of the commercial insurance business, tied to disputes with out-of-network providers and higher-than-expected medical costs.
Why the stock moved this much is not fully settled
Most reporting ties the drop directly to the TPG news breaking the same morning as the conference remarks. But the size of the move also lines up with other pressure points that day: UnitedHealth is also about to pay a $2.32-per-share quarterly dividend, and only shareholders who still hold the stock as of September 14, 2026 will qualify for that payment. Investors sometimes sell just before a dividend cutoff date like that — a pattern traders call trading “ex-dividend” — rather than hold on and wait for the next payout, and CoinCentral counted that kind of selling among the factors behind its reported 5.2% figure for the day.
The broader market was also soft that day: the S&P 500 was down about 0.3% and the Dow was down about 0.7%, amid rising expectations of a Federal Reserve rate hike following strong August employment data. By contrast, one report put the Health Care Select Sector SPDR ETF, which tracks the healthcare sector as a whole, down only about 0.4% the same day, suggesting UnitedHealth’s move was more company-specific than a broad sector-wide decline.
Not the same story as January’s roughly 20% stock rout
Readers who remember UnitedHealth stock falling sharply earlier this year should note this is a separate event. That January 27, 2026 drop, roughly 20%, followed weak fourth-quarter 2025 earnings, the company’s first-ever revenue-decline warning, and Medicaid margin problems, alongside a separate, ongoing Justice Department criminal antitrust investigation into UnitedHealth’s Claritev subsidiary. Wednesday’s move is tied to the Florida clinic sale and the healthcare-conference remarks, not to that earlier investigation or to the company’s Q2 2026 earnings report.
What it means for shareholders
The companies have not disclosed the size of the stake or what TPG paid for it. For current shareholders, some market-data summaries cite September 14, 2026 as the record date for the $2.32 quarterly dividend.